Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression.

Iizuka S, Ishimaru N, Kudo Y.

Cancers (Basel). 2014 Feb 13;6(1):396-415. doi: 10.3390/cancers6010396.

2.

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA.

Cancer Res. 2000 Feb 15;60(4):1121-8.

3.

Matrix metalloproteases in head and neck cancer.

Rosenthal EL, Matrisian LM.

Head Neck. 2006 Jul;28(7):639-48. Review.

5.

Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.

O-Charoenrat P, Rhys-Evans PH, Eccles SA.

Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):813-20.

PMID:
11448356
6.

Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.

Umbreit C, Aderhold C, Faber A, Sauter A, Hofheinz RD, Stern-Straeter J, Hoermann K, Schultz JD.

Oncol Rep. 2014 Aug;32(2):668-76. doi: 10.3892/or.2014.3225.

PMID:
24890748
7.

MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.

Birkedal-Hansen B, Pavelic ZP, Gluckman JL, Stambrook P, Li YQ, Stetler-Stevenson WG.

Oral Dis. 2000 Nov;6(6):376-82.

PMID:
11355270
8.

Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.

Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H.

Hum Pathol. 2000 Aug;31(8):895-904.

PMID:
10987249
9.

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.

Merdad A, Karim S, Schulten HJ, Dallol A, Buhmeida A, Al-Thubaity F, Gari MA, Chaudhary AG, Abuzenadah AM, Al-Qahtani MH.

Anticancer Res. 2014 Mar;34(3):1355-66.

PMID:
24596383
10.

The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck.

Werner JA, Rathcke IO, Mandic R.

Clin Exp Metastasis. 2002;19(4):275-82. Review.

PMID:
12090467
11.
12.

The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.

Zhang Z, Yang XF, Huang KQ, Ren L, Zhao S, Gou WF, Shen DF, Sun HZ, Takano Y, Zheng HC.

Tumour Biol. 2016 Feb;37(2):1671-81. doi: 10.1007/s13277-015-3901-5.

PMID:
26311049
13.

Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo.

Zhang W, Matrisian LM, Holmbeck K, Vick CC, Rosenthal EL.

BMC Cancer. 2006 Mar 6;6:52.

14.
15.

MT1-MMP and MMP-7 in invasion and metastasis of human cancers.

Shiomi T, Okada Y.

Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):145-52. Review.

PMID:
12784993
16.
17.

Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro.

Aderhold C, Umbreit C, Faber A, Birk R, Sommer JU, Hörmann K, Schultz JD.

Anticancer Res. 2014 Sep;34(9):4929-37.

PMID:
25202075
18.

Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression.

Canel M, Secades P, Garzón-Arango M, Allonca E, Suarez C, Serrels A, Frame M, Brunton V, Chiara MD.

Br J Cancer. 2008 Apr 8;98(7):1274-84. doi: 10.1038/sj.bjc.6604286.

19.

Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines.

Schröpfer A, Kammerer U, Kapp M, Dietl J, Feix S, Anacker J.

BMC Cancer. 2010 Oct 13;10:553. doi: 10.1186/1471-2407-10-553.

20.

Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.

Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O.

Cancer. 2002 Nov 1;95(9):1902-10.

Supplemental Content

Support Center